PUBLICATIONS -- Some are authored as Robin C. Stong and some as Robin S. Treichel

1. Stong RC, Stone WH: The human Duffy blood group in rhesus monkeys. Anim Blood Grps biochem Genet 11: 185-192, 1980.

2. Stone WH, Stong RC, Blazkovec AA, Blystad C, Houser WD: Animal models of erythrocyte destruction: Why aren't the erythrocytes of the newborn rhesus destroyed by maternal antibodies? Immunobiology of the Erythrocyte, (SG Sandler, J Nusbacher, MS Schanfield, Eds), A.R. Liss, NY, pp. 237-249, 1980.

3. Stong RC, Houser WD, Stone WH: The absence of hemolytic disease in the newborn rhesus monkey (Macaca mulatta). Vet Immunol Immunopathol 3: 611-627, 1982.

4. Stong RC, Stone WH: Mononuclear phagocyte receptors in rhesus monkeys (Macaca mulatta) and their role in immune elimination of erythrocytes. Vet Immunol Immunopathol 7: 101-117, 1984.

5. Stong RC, Nelson K, Stone WH: Transplacental alloimmunization to fetal erythrocytes in rhesus monkeys (Macaca mulatta). Am J Reprod Immunol 6: 128-132, 1984.

6. Stong RC, Korsmeyer SJ, Parkin J, Arthur DC, Kersey JH: Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B-lineage and monocytic characteristics. Blood 65: 21-31, 1985.

7. Stong RC, Youle RJ, Vallera DA: Elimination of clonogenic T leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Cancer Res 44: 3000-3006, 1984.

8. Kersey JH, Vallera D, Ramsay N, Filipovich A, Stong R, LeBien T, Youle R, Neville D, Beverley P: Monoclonal antibodies for purging bone marrow of acute lymphoblastic leukemia or graft versus host producing cells: antibody plus complement or immunotoxins. Proc. International Symposium on Detection and Treatment of Minimal Residual Disease in Acute Leukemia, (B Lowenberg, A Hagenbeek, Eds), Martinus Nijhoff, Boston, 1984.

9. LeBien TW, Stepan DE, Bartholomew RM, Stong RC, Anderson JM: Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement. Blood 65: 945-950., 1985.

10. Kersey JH, Vallera D, Ramsay N, Filipovich A, Stong RC, LeBien T, Youle R, Neville D. Monoclonal antibodies and immunotoxins in bone marrow transplantation: purging marrow of ALL or GVHD cells with preservation of stem cells. Modern Trends In Human Leukemia VI, (R Neth, et al., Eds). Haematology of Blood Transfusion 29: 34-38, 1985.

11. Stong RC, Youle RJ, Kersey JH, Zanjani ES, Vallera DA: Use of a cocktail of monoclonal antibody-intact ricin conjugates to purge human bone marrow of leukemic cells. Proc. First International Symposium on Autologous Bone Marrow Transplantation, (K Dicke, G Spitzer, A Zander, N Gorin, Eds), Gulf Coast Printing, pp 455-459, 1985.

12. Filipovich AH, Vallera DA, Youle R, Stong R, Neville DM Jr., Kersey JH: Marrow purging with immunotoxins in allogeneic and autologous bone marrow transplantation: pilot clinical studies. Proc. First International Symposium on Autologous Bone Marrow Transplantation, (K Dicke, G Spitzer, A Zander, N Gorin, Eds), Gulf Coast Printing, pp 403-407, 1985.

13. Stong RC, Kersey JH: In vitro culture of leukemic cells in t(4:11) leukemia. Blood 66: 439-443, 1985.

14. Stong RC, Uckun FM, Youle RJ, Kersey JH, Vallera DA: Use of multiple T-cell directed intact ricin immunotoxins for autologous bone marrow transplantation. Blood 66: 627-635, 1985.

15. Uckun FM, Stong RC, Youle RJ, Vallera DA: Combined ex vivo treatment with immunotoxins and mafosfamid: A novel immunochemotherapeutic approach for elimination of neoplastic T-cells from autologous marrow grafts. J Immunol 134: 3504-3515, 1985.

16. Stone WH, Treichel RCS, VandeBerg JL: Genetic significance of some common primate models in biomedical research. In: Animal Models: Assessing the Scope of Their Use in Biomedical Research, (J Kawamata and EC Melby, Jr., Eds.), A.R. Liss, pp 73-93, 1987.

17. Treichel RS: Immunogenetic studies of maternal-fetal relationships. A review: Why newborn rhesus monkeys do not get hemolytic disease. Genetica 73: 69-79, 1987.

18. Treichel RS: Natural killer cells. Magill's Survey of Science: Life Science, (FN Magill, Ed.), pp 1863-1869, Salem Press, Pasadena, CA, 1991.

19. Treichel RS: Sabin Develops an Oral Polio Vaccine. In: Great Events from History II: Science and Technology, (FN Magill, Ed.), pp. 1522-1527, Salem Press, Pasadena, CA, 1991.

20. Treichel RS, Olken S: The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines. Intl J Cancer 50:305-310, 1992.

21. Cruz YP, Treichel RS, Harsay E, Chi KD: Mouse blastocyst immunosurgery with commercial antiserum to mouse erythrocytes. In Vitro Cellular & Developmental Biology 29A:671-675, 1993.

22. Treichel RS: Autologous bone marrow transplantation for leukemia: monoclonal antibody-mediated purging of multidrug-resistant leukemia. Leukemia Research 17(6): 491-499, 1993.

23. Treichel RS: Susceptibility to LAK-mediated cytotoxicity of multidrug-resistant variants of the human RAJI cell line is not related to expression of major cellular adhesion molecules. J Ohio Acad Sci 93:14-18, 1993.

24. Treichel Robin S: �Computer Enhanced Teaching of Cell and Molecular Biology�, book chapter in Interactive Learning: Vignettes from America�s Most Wired Campuses, (DG Brown, Ed) Anker Publishing Co. Inc., Boston, 2000.

25. Treichel RS, Bunuan M, Hahn N, Wee K. Altered conjugate formation and altered apoptosis of multidrug-resistant human leukemia cell line affects susceptibility to killing by activated natural killer (NK) cells. Intl J Cancer, 108: 78-85, 2004.

26. Salter RM, Treichel RS: A Bioinformatics course for biologists and computer scientists on foreign study. Transformations: Liberal Arts in the Digital Age Vol 2, Issue 1, May 2004. Transformations: Liberal Arts in the Digital Age. Vol 2, Issue 1, May 2004.